Name Development  |  (USAN / INN) Nonproprietary Naming

Brand Institute provides the finest nonproprietary NAME DEVELOPMENT, marketing research and design services in the industry, serviced locally by experienced professionals. Our naming services include:

Drug Safety Institute, a subsidiary of Brand Institute, provides regulatory nonproprietary Naming research, labeling, packaging, and risk management services utilizing proven methodologies developed by the most highly qualified personnel.

Drug Safety Institute can provide strategic guidance that will assist you in navigating the pharmaceutical naming process from initiation through regulatory submission.

Sophia V. Fuerst nee Rybak

Ms. Fuerst is Managing Director of the Drug Safety Institute's Nonproprietary (USAN/INN) Names Division. Ms. Fuerst was formerly Director of the USAN Program at the American Medical Association and served in various positions during her 18-year tenure with the Program.

She was involved in negotiations between the USAN Council, pharmaceutical manufacturers and foreign nomenclature agencies. From 1986 to 2005 Ms. Fuerst was responsible for reviewing submissions, classifying compounds, creation of new stems when appropriate and approval and adoption of new USAN.

Ms. Fuerst also sat on the World Health Organization (WHO/INN) Committee and served as AMA's senior staff scientist in the area of Drug Nomenclature.

Ms. Fuerst holds a B.S. in Biology/Chemistry (pre-med) from St. Joseph's College, an M.S. in Medicinal Chemistry from the University of Chicago and an M.B.A. from Governor's State University in Illinois